Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Psoriasis 2Pruritus 1Lymphoma, Follicular 1Congenital Abnormalities 1Autoimmune Diseases 1Arthritis, Psoriatic 1

Interventions

telitacicept 3fludarabine 3Prednisone 3Data Collection 3Cyclophosphamide 3Specimen Handling 2Nivolumab 2Blood Specimen Collection 2Antilymphocyte Serum 2thymoglobulin 1remdesivir 1prednylidene 1human papillomavirus vaccine, L1 type 16, 18 1deltacortene 1carmustine, poliferprosan 20 drug combination 1cabozantinib 1apremilast 1Watchful Waiting 1Vitamin D 1Valsartan 1Telemedicine 1Surveys and Questionnaires 1Standard of Care 1Pyridostigmine Bromide 1Practice Guidelines as Topic 1Population Groups 1Platinum Compounds 1Plasma Exchange 1Phlebotomy 1Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Autoimmune Diseases × apremilast × Clear all
NCT02775500 2025-01-28

Apremilast Pregnancy Exposure Registry

University of California, San Diego

Active not recruiting
233 enrolled

Congenital Abnormalities, Autoimmune Diseases, Psoriasis, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡